I am a total skeptic as it relates to the development of drugs in the United States. I think it is a rigged and corrupt system. That is, however, not the point of my blog post today.
Today we speak of Biogen’s newest drug, the recently US Food and Drug Administration approved Alzheimer’s drug: ADUCANUMAB.
[The marketing guys got ahold of the boss and the drug will be marketed under the name ADUHELM. I know, not much of a name, but beats the Hell out of aducanumab.]